G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Moderna: BioNTech is claiming work ‘it never did’

12 June 2026 In a strong response to BioNTech, Moderna argues its next-gen vaccine is built on a fundamentally different design from the German biotech’s—setting up a scrap over whether a key patent should have been granted.

Europe

Siemens ordered to recall mammography device across European countries

11 June 2026 The UPC has dealt Siemens a loss against a rival US medtech company, upholding a key breast imaging patent and addressing a range of issues from infringement and validity to recall orders and software-based workarounds.

Careers

MoFo bags IP trial duo with 50 years’ combined experience

11 June 2026 The opportunity to grow a “powerhouse IP litigation practice in the heart of New York” was behind the lateral move of highly experienced litigators to Morrison Foerster.

More features

European court backs AstraZeneca unit in blood cancer combo dispute

Boehringer Ingelheim adds ex-Teva executive to patent team

AI, anxiety, and antibodies: The issues dominating life sciences

Healthcare leads sweeping AI partnership in Singapore

WATCH: Interview with Mythili Markowski, director at Regeneron

Patent office fee increases: What applicants must know

UK patent office adopts EPO standards for AI inventions

Closing the women's health gap offers ‘benefits for all’

G 2/21: how to support inventive steps in patentability

More on this story

Editor's picks

Editor's picks

More features